Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · IEX Real-Time Price · USD
10.24
+1.06 (11.55%)
May 3, 2024, 12:27 PM EDT - Market open
Vir Biotechnology Employees
Vir Biotechnology had 587 employees on December 31, 2023. The number of employees increased by 11 or 1.91% compared to the previous year.
Employees
587
Change (1Y)
11
Growth (1Y)
1.91%
Revenue / Employee
$146,814
Profits / Employee
-$1,047,804
Market Cap
1.39B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 587 | 11 | 1.91% |
Dec 31, 2022 | 576 | 132 | 29.73% |
Dec 31, 2021 | 444 | 117 | 35.78% |
Dec 31, 2020 | 327 | 98 | 42.79% |
Dec 31, 2019 | 229 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Phreesia | 1,438 |
AtriCure | 1,050 |
Gyre Therapeutics | 593 |
Mirum Pharmaceuticals | 264 |
Collegium Pharmaceutical | 197 |
Prothena Corporation | 173 |
Scholar Rock Holding | 150 |
Verona Pharma | 79 |
VIR News
- 20 hours ago - Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results - Business Wire
- 2 days ago - Vir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024 - Business Wire
- 15 days ago - Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. - Business Wire
- 21 days ago - Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024 - Business Wire
- 2 months ago - Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule - Business Wire
- 2 months ago - Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences - Business Wire
- 2 months ago - Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results - Business Wire
- 3 months ago - Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024 - Business Wire